What is Sermorelin?
Sermorelin acetate is a 29-amino acid synthetic analog of human growth hormone-releasing hormone (
Sermorelin — native GHRH(1-29) fragment
In short
29-amino acid GHRH fragment studied in endocrine models for pulsatile stimulation of pituitary somatotropic secretion.
Overview
Sermorelin acetate is a 29-amino acid synthetic analog of human growth hormone-releasing hormone (
Subcutaneous injection provides optimal bioavailability with rapid onset (5-20 minutes) and physiological pulsatile stimulation
Molecular information
First-order decay curve at 0.2h half-life from literature. Educational only.
Research indications
Grouped by area. Each entry reflects a separate published hypothesis or clinical signal - not medical advice.
Most native analog - reference for research requiring natural pulses without modification confounders.
Проследявайте функцията на щитовидната жлеза. Около 6.5% от пациентите развиват хипотиреоидизъм, изискващ хормонално заместване. Проверявайте нивата на ежемесечно в началото, а след това на всеки 3 до 6 месеца. Реакции на мястото на инжектиране се наблюдават при 16.7% от пациентите, но обикновено са леки. Противопоказан е при активни злокачествени заболявания, тумори на хипофизата и бременност. Сигнали за спиране: Признаци на растеж на тумор на хипофизата (главоболие, промени в зрението). Тежки реакции на мястото на инжектиране или общи алергични реакции. Неконтролиран диабет или развитие на значителна непоносимост към глюкоза. Поява на нови или влошаване на съществуващи симптоми на злокачествено заболяване.
4 peer-reviewed sources
References
Links to peer-reviewed publications on PubMed, cited in the peptide's scientific profile.
Guillemin discovery
Foundational | Various | Various | GHRH(1-29) identification (Nobel 1977)
Science · 1982
View the studyInformation about Sermorelin is based on published scientific research and is intended for research purposes only. Not medical advice.
Products are for in vitro laboratory research only. Not approved for human consumption.
Other peptides
5-Amino-1MQ
5-Amino-1MQ is a small-molecule selective inhibitor of NNMT (nicotinamide N-methyltransferase), identified by Anthony Sauve (Cornell) in 2018. NNMT is a "metabolic sink" for methyl donors and NAD+ — suppressing it in adipocytes raises energy expenditure without reducing calorie intake.
ReadAdipotide
Adipotide is a target peptide developed by Wadih Arap and Renata Pasqualini (MD Anderson) for selective elimination of white adipose tissue. It binds prohibitin on adipocyte vasculature and induces apoptosis of the blood vessels supplying fat tissue — leading to nonsurgical fat reduction.
ReadAOD-9604
AOD-9604 is a modified C-terminal 16-amino-acid fragment of human growth hormone (177-191), supplemented with a tyrosine residue. Retains the lipolytic effect of the full molecule but without diabetogenic or GH-stimulating activity. Developed by Metabolic Pharmaceuticals (Australia) in the 1990s.
ReadARA-290
ARA-290 (Cibinetide) is an 11-amino-acid fragment of erythropoietin (EPO) developed by Anthony Cerami as a cytoprotective molecule without erythropoietic activity. It retains the tissue-protective effects of EPO without raising hematocrit — explaining its potential in diabetic neuropathy and cardiac applications.
ReadArgireline
Argireline is a synthetic acetylated hexapeptide (Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2) derived from SNAP-25 — the SNARE complex subunit mediating acetylcholine release at neuromuscular junctions. Topical application reduces muscle activity in expression areas — which is why Argireline is marketed as a "topical Botox alternative".
ReadBPC-157
BPC-157 is a 15-amino-acid fragment isolated from a protective protein in human gastric juice — hence the name Body Protection Compound. Over thirty years of research by Predrag Sikiric's group at the University of Zagreb (100+ peer-reviewed papers) establish its angiogenic action through the VEGFR2 receptor and its stimulation of fibroblasts. If you work with in vitro models of tendon, muscle or gut tissue, BPC-157 is among the most extensively documented regenerative peptides.
ReadNo comments yet. Be the first.
Comments are reviewed before publishing.